What symptoms can be expected on day 11 after discontinuing Latuda (lurasidone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What to Expect on Day 11 After Stopping Latuda

By day 11 after discontinuing Latuda (lurasidone), most patients should expect minimal to no acute withdrawal symptoms, though there is a risk of gradual return of underlying psychiatric symptoms (depression or psychosis) that may emerge over the following weeks to months.

Timeline of Discontinuation Effects

Immediate Withdrawal Period (Days 1-7)

The acute discontinuation phase has largely passed by day 11. Research shows that antipsychotic efficacy persists for several days after stopping the medication, with minimal symptom worsening during short-term discontinuation up to 3 weeks 1. The mean symptom changes during the first week off antipsychotics are clinically insignificant.

Day 11 Status (Current Timeline)

At this point, you are past the typical acute withdrawal window but entering the period where:

  • Extrapyramidal symptoms (EPS) may still be resolving: If you experienced akathisia (restlessness), dystonia, or parkinsonism while on Latuda, these should be improving or resolved. The FDA label indicates these occur in 9-22% of patients depending on dose 22.

  • Common side effects should be gone: Nausea (14-16%), somnolence (11-15%), and akathisia (9-12%) that occurred during treatment should have resolved 2.

  • Underlying condition symptoms may begin returning: This is the critical concern. Patients with mood and anxiety disorders "may be able to have their medication tapered only to have a return of symptoms weeks to months after their last dose" 3.

Key Symptoms to Monitor

Watch for Return of Original Condition:

  • If treated for bipolar depression: Monitor for depressed mood, anhedonia, sleep changes, suicidal thoughts
  • If treated for schizophrenia: Watch for psychotic symptoms, disorganization, paranoia
  • Manic symptoms: Increased energy, decreased sleep need, irritability (particularly relevant as lurasidone discontinuation in inadequately stabilized patients can unmask mania) 4

Physical Symptoms (Should Be Minimal by Day 11):

  • Any lingering EPS symptoms should continue improving
  • Urinary retention (rare side effect) should resolve if present 5

Critical Monitoring Period Ahead

The next 4-12 weeks are more important than day 11 itself. The guideline emphasizes that "patients with mood and anxiety disorders may be able to have their medication tapered only to have a return of symptoms weeks to months after their last dose" 3. This delayed return of symptoms is the primary risk, not acute withdrawal.

Common Pitfalls to Avoid

  • Assuming you're "clear" at day 11: The absence of symptoms now doesn't mean your underlying condition won't re-emerge
  • Stopping monitoring too early: Extended monitoring for weeks to months is necessary 3
  • Abrupt discontinuation without a plan: While research suggests abrupt discontinuation doesn't worsen outcomes in the short term 1, having a monitoring plan is critical for detecting symptom return

What You Should Be Doing Now

  • Continue daily monitoring of mood, sleep, and psychotic symptoms
  • Maintain regular follow-up with your prescriber
  • Have a clear plan for what to do if symptoms return
  • Ensure support systems are aware of warning signs to watch for

The evidence strongly suggests that day 11 itself is not a high-risk period for acute problems, but rather marks the beginning of the window where underlying psychiatric symptoms may gradually re-emerge over subsequent weeks.

References

3
Guideline

practice parameter on the use of psychotropic medication in children and adolescents.

Journal of the American Academy of Child and Adolescent Psychiatry, 2009

Related Questions

What symptoms should I expect after discontinuing lurasidone (Latuda) 40 mg for eight days?
After stopping Latuda (lurasidone) abruptly after 22 days, when can I expect my neurological function to return to normal?
I stopped Latuda (lurasidone) 7 days ago; can discontinuation cause mental fog, and how long might it last?
Can lurasidone (Latuda) cause yellow, loose stools?
What can I expect after stopping Latuda (lurasidone) after 13 days of use?
Is ketorolac (Toradol) safe to use after ventriculoperitoneal shunt placement and pellucidotomy surgery?
What is the optimal management for a 70-year-old male with peripheral arterial disease causing claudication, opioid use disorder, hypertension, and type 2 diabetes mellitus?
What are the long-term sequelae of Naegleria fowleri infection?
In a 70-year-old woman with a brief, self-limited loss of sensation in both feet and a creatine kinase level of 241 U/L, what is the appropriate initial evaluation and management?
A 29-year-old male with schizophrenia and a prior good response to clozapine presenting with a psychotic episode—what is the recommended management?
What is the incubation period of Naegleria fowleri infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.